Emcure Pharmaceuticals' Poviztra Gets CDSCO Approval For MASH Treatment

Emcure received CDSCO approval to expand Poviztra® (semaglutide) for MASH in adults with moderate-to-advanced liver fibrosis. It becomes the first GLP-1 receptor agonist approved for MASH in India, broadening the drug's metabolic disease portfolio and addressing unmet need.